SCHEMBL32688155

SCHEMBL32688155

N#Cc1c(S)[nH]c(=O)c(C#N)c1-c1cccc(-c2ccc(Cl)cc2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 5/20 0.49
▸ TDO2 P48775 1/20 0.49
▸ KDM4E B2RXH2 4/20 0.44
▸ ALDH1A1 P00352 3/20 0.44
▸ GLA P06280 3/20 0.44
▸ GAA P10253 3/20 0.44
▸ LMNA P02545 3/20 0.44
▸ HPGD P15428 2/20 0.44
▸ HTT P42858 2/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ CRHBP P24387 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ CRHR2 Q13324 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ RXFP1 Q9HBX9 1/20 0.44
▸ BIRC5 O15392 1/20 0.43
▸ PIM1 P11309 1/20 0.42
▸ ATM Q13315 1/20 0.42
▸ MCL1 Q07820 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32688430 0.89 PDE9A (0.50) IDO1TDO2KDM4EALDH1A1GLA
SCHEMBL32688107 0.89 IDO1 (0.57) IDO1TDO2KDM4EALDH1A1GLA
SCHEMBL32688143 0.84 ALDH1A1 (0.45) IDO1TDO2KDM4EALDH1A1GLA
SCHEMBL32688065 0.84 KDM4E (0.50) KDM4EALDH1A1GLAGAAHPGD
SCHEMBL32688154 0.82 PDE9A (0.57) IDO1KDM4EALDH1A1GLAGAA
SCHEMBL32688480 0.81 KDM4E (0.51) IDO1TDO2KDM4EALDH1A1GLA
SCHEMBL32687975 0.78 KDM4E (0.47) IDO1KDM4EALDH1A1GLAGAA
SCHEMBL32688005 0.76 PDE9A (0.43) IDO1KDM4EMEN1KMT2APDE9A
SCHEMBL32688013 0.74 PDE9A (0.43) IDO1KDM4EMEN1KMT2APDE9A
SCHEMBL32688011 0.74 PDE9A (0.43) IDO1KDM4EMEN1KMT2APDE9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK IDO1 1284/4885TDO2 1470/4885KDM4E 3207/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback